Terry M. Therneau

85.4k citations

403 papers · 58.1k indexed · 22 hit papers · h-index 107

Hepatology top 0.02%
- Liver Disease and Transplantation 44
- Liver Diseases and Immunity 29
Hematology top 0.05%
- Multiple Myeloma Research and Treatments 48
Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment 82
Statistics and Probability top 0.05%
Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 28
Rheumatology
- Rheumatoid Arthritis Research and Therapies 25
Surgery
- Organ Transplantation Techniques and Outcomes 24
Psychiatry and Mental health
- Dementia and Cognitive Impairment Research 24

Co-authors: Patricia M. Grambsch Peter McCullagh J. A. Nelder W. Ray Kim Robert A. Kyle S. Vincent Rajkumar Dirk R. Larson Russell H. Wiesner
Cited by: Hepatology Hematology Epidemiology
Partner nations: United States Belarus South Korea

In The Last Decade

Terry M. Therneau

396 papers receiving 56.3k citations

Hit Papers

15 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
2018 Longitudinal tau PET in ageing and Alzheimer’s disease
2016 Defining imaging biomarker cut points for brain aging and Alzheimer's disease
2015 An Introduction to Recursive Partitioning Using the RPART Routines
2015 Recursive Partitioning and Regression Trees
2012 Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
2011 Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
2010 Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007
2010 The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases
2008 Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2007 Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
2007 The NAFLD fibrosis score
2006 Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
2006 Prevalence of Monoclonal Gammopathy of Undetermined Significance
2004 Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
2003 Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2002 A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
2001 A Model to Predict Survival in Patients With End–Stage Liver Disease
2000 Modeling Survival Data: Extending the Cox Model
1994 Proportional hazards tests and diagnostics based on weighted residuals
1993 Generalized Linear Models (2nd ed.).
1990 Martingale-based residuals for survival models

Peers

Countries citing papers authored by Terry M. Therneau

Since Specialization

Citations

This map shows the geographic impact of Terry M. Therneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry M. Therneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry M. Therneau more than expected).

Fields of papers citing papers by Terry M. Therneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry M. Therneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry M. Therneau. The network helps show where Terry M. Therneau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Terry M. Therneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terry M. Therneau Line = papers co-authored together Terry M. Therneau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Staging Alzheimer’s disease through amyloid and tau PET Derek R. Johnson,Heather J. Wiste,Val J. Lowe,Christopher G. Schwarz,David S. Knopman,Prashanthi Vemuri,Kejal Kantarci,Bradley F. Boeve,Jonathan Graff‐Radford,Petrice M. Cogswell,Matthew L. Senjem,Terry M. Therneau,Michael Griswold,Mingzhao Hu,Ronald Petersen,Clifford R. Jack	2025	0
2	Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PET Petrice M. Cogswell,Emily S. Lundt,Terry M. Therneau,Heather J. Wiste,Jonathan Graff‐Radford,Alicia Algeciras‐Schimnich,Val J. Lowe,Michelle M. Mielke,Christopher G. Schwarz,Matthew L. Senjem,Jeffrey L. Gunter,David S. Knopman,Prashanthi Vemuri,Ronald C. Petersen,Clifford R. Jack	2023	14
3	Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH Jiahui Li,Xin Lü,Zheng Zhu,Kyle Kalutkiewicz,Taofic Mounajjed,Terry M. Therneau,Sudhakar K. Venkatesh,Yi Sui,Kevin J. Glaser,Safa Hoodeshenas,Armando Manduca,Vijay H. Shah,Richard L. Ehman,Alina M. Allen,Meng Yin	2023	13
4	Predicting amyloid PET and tau PET stages with plasma biomarkers Clifford R. Jack,Heather J. Wiste,Alicia Algeciras‐Schimnich,Daniel J. Figdore,Christopher G. Schwarz,Val J. Lowe,Vijay K. Ramanan,Prashanthi Vemuri,Michelle M. Mielke,David S. Knopman,Jonathan Graff‐Radford,Bradley F. Boeve,Kejal Kantarci,Petrice M. Cogswell,Matthew L. Senjem,Jeffrey L. Gunter,Terry M. Therneau,Ronald C. Petersen	2023	67
5	CSF phosphorylated tau as an indicator of subsequent tau accumulation Petrice M. Cogswell,Heather J. Wiste,Michelle M. Mielke,Christopher G. Schwarz,Stephen D. Weigand,Val J. Lowe,Terry M. Therneau,David S. Knopman,Jonathan Graff-Radford,Prashanthi Vemuri,Matthew L. Senjem,Jeffrey L. Gunter,Alicia Algeciras-Schimnich,Ronald C. Petersen,Clifford R. Jack	2022	4
6	Longitudinal Changes in MR Elastography–based Biomarkers in Obese Patients Treated with Bariatric Surgery Jiahui Li,Alina M. Allen,Vijay H. Shah,Armando Manduca,Richard L. Ehman,Meng Yin,Terry M. Therneau,Taofic Mounajjed,Kevin J. Glaser,Sudhakar K. Venkatesh	2021	8
7	NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages Ronald C. Petersen,Heather J. Wiste,Stephen D. Weigand,Julie A. Fields,Yonas E. Geda,Jonathan Graff‐Radford,David S. Knopman,Walter K. Kremers,Val J. Lowe,Mary M. Machulda,Michelle M. Mielke,Nikki H. Stricker,Terry M. Therneau,Prashanthi Vemuri,Clifford R. Jack	2021	42
8	Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis Jie Chen,Alina M. Allen,Terry M. Therneau,Jun Chen,Jiahui Li,Safa Hoodeshenas,Jingbiao Chen,Xin Lü,Zheng Zhu,Sudhakar K. Venkatesh,Bin Song,Richard L. Ehman,Meng Yin	2021	18
9	Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers Petrice M. Cogswell,Heather J. Wiste,Matthew L. Senjem,Jeffrey L. Gunter,Stephen D. Weigand,Christopher G. Schwarz,Arvin Arani,Terry M. Therneau,Val J. Lowe,David S. Knopman,Hugo Botha,Jonathan Graff‐Radford,David T. Jones,Kejal Kantarci,Prashanthi Vemuri,Bradley F. Boeve,Michelle M. Mielke,Ronald C. Petersen,Clifford R. Jack	2020	75
10	Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma Sravanthi Lavu,Terry M. Therneau,William S. Harmsen,Kristin C. Mara,Nicha Wongjarupong,Mohamed A. Hassan,Hamdi A. Ali,Samuel O. Antwi,Nasra H. Giama,Katsuyuki Miyabe,Lewis R. Roberts	2020	20
11	Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery Alina M. Allen,Vijay H. Shah,Terry M. Therneau,Sudhakar K. Venkatesh,Taofic Mounajjed,Joseph J. Larson,Kristin C. Mara,Todd A. Kellogg,Michael L. Kendrick,Travis J. McKenzie,Suzanne Greiner,Jiahui Li,Kevin J. Glaser,Michael Wells,Timothy J. Gunneson,Richard L. Ehman,Meng Yin	2019	32
12	The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes Clifford R. Jack,Heather J. Wiste,Hugo Botha,Stephen D. Weigand,Terry M. Therneau,David S. Knopman,Jonathan Graff‐Radford,David T. Jones,Tanis J. Ferman,Bradley F. Boeve,Kejal Kantarci,Val J. Lowe,Prashanthi Vemuri,Michelle M. Mielke,Julie A. Fields,Mary M. Machulda,Christopher G. Schwarz,Matthew L. Senjem,Jeffrey L. Gunter,Ronald C. Petersen	2019	126
13	The rationale, design, and methods of a randomized, controlled trial to evaluate the effectiveness of collaborative telecare in preserving function among patients with late stage cancer and hematologic conditions Andrea Cheville,Timothy J. Moynihan,Jeffrey R. Basford,John A. Nyman,Marty L. Tuma,Debra A. Macken,Terry M. Therneau,Daniel Satelel,Kurt Kroenke	2017	18
14	Assessing calibration of prognostic risk scores Cynthia S. Crowson,Elizabeth J. Atkinson,Terry M. Therneau	2013	170
15	Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United Statesbreakdown → Donghee Kim,W. Ray Kim,Hwa Jung Kim,Terry M. Therneau	2012	600
16	Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance Celine M. Vachon,Robert A. Kyle,Terry M. Therneau,Barbara J. Foreman,Dirk R. Larson,Colin Colby,Tara K. Phelps,Angela Dispenzieri,Shaji Kumar,Jerry A. Katzmann,S. Vincent Rajkumar	2009	87
17	Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study L. Joseph Melton,Cynthia L. Leibson,Sara J. Achenbach,Terry M. Therneau,Sundeep Khosla	2008	314
18	Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma Angela Dispenzieri,Robert A. Kyle,Jerry A. Katzmann,Terry M. Therneau,Dirk R. Larson,Joanne Benson,Raynell Clark,L. Joseph Melton,Morie A. Gertz,Shaji Kumar,Rafaël Fonseca,Diane F. Jelinek,S. Vincent Rajkumar	2007	285
19	A Prospective Study of CD38/45 Flow Cytometry and Immunofluorescence Microscopy to Detect Blood Plasma Cells in Patients with Plasma Cell Proliferative Disorders Thomas E. Witzig,Cecelia H. Meyers,Terry M. Therneau,Philip R. Greipp	2000	5
20	Epidemiology and natural history of primary biliary cirrhosis in a U.S. community W. Ray Kim,Keith D. Lindor,G. Richard Locke,Terry M. Therneau,Henry A. Homburger,Kenneth P. Batts,Barbara P. Yawn,Janice L. Petz,L. Joseph Melton,E. Rolland Dickson	2000	257

About Terry M. Therneau

Terry M. Therneau is a scholar working on Hepatology, Hematology and Genetics, having authored 403 papers that have together received 58.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (82 papers), Multiple Myeloma Research and Treatments (48 papers), Liver Disease and Transplantation (44 papers), Liver Diseases and Immunity (29 papers), Chronic Lymphocytic Leukemia Research (28 papers), Rheumatoid Arthritis Research and Therapies (25 papers), Organ Transplantation Techniques and Outcomes (24 papers) and Dementia and Cognitive Impairment Research (24 papers). The work is most often cited by research in Hepatology (12.7k citations), Hematology (7.8k citations) and Epidemiology (15.6k citations). Terry M. Therneau has collaborated with scholars based in United States, Belarus and South Korea. Frequent co-authors include Patricia M. Grambsch, Peter McCullagh, J. A. Nelder, W. Ray Kim, Robert A. Kyle, S. Vincent Rajkumar, Dirk R. Larson, Russell H. Wiesner, Patrick S. Kamath and Angela Dispenzieri.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact